Australia markets close in 5 hours 30 minutes

Bellerophon Therapeutics, Inc. (BLPH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0550+0.0009 (+1.66%)
At close: 11:46AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
15,808
16,362
13,015
17,890
Selling general and administrative
5,764
6,022
7,146
8,386
Total operating expenses
21,572
22,384
20,161
26,276
Operating income or loss
-21,572
-22,384
-20,161
-26,276
Interest expense
-
-
-
250
Total other income/expenses net
-
1
600
-327
Income before tax
-21,504
-22,248
-19,556
-26,853
Income tax expense
-2,417
-2,417
-1,800
-2,125
Income from continuing operations
-19,087
-19,831
-17,756
-24,728
Net income
-19,087
-19,831
-17,756
-24,728
Net income available to common shareholders
-19,087
-19,831
-17,756
-24,728
Basic EPS
-0.89
-2.08
-1.87
-3.17
Diluted EPS
-0.89
-2.08
-1.87
-3.17
Basic average shares
11,103
9,551
9,503
7,797
Diluted average shares
11,103
9,551
9,503
7,797